Copyright
©The Author(s) 2025.
World J Cardiol. May 26, 2025; 17(5): 106123
Published online May 26, 2025. doi: 10.4330/wjc.v17.i5.106123
Published online May 26, 2025. doi: 10.4330/wjc.v17.i5.106123
Table 1 Overview of studies on circulating microRNAs in predicting fibrosis in hypertrophic cardiomyopathy
Ref. | Study design | Sample size | Population | Method of miRNA detection | Method of fibrosis assessment | Key findings |
Human studies | ||||||
Angelopoulos et al[23] | Case-control study | 50 | 27 HCM patients, 13 hypertensive cardiomyopathy patients, 10 controls | miR-21 and -29 assessed by qRT-PCR | LGE by CMR | miR-21 upregulated in HCM and correlated with extensive myocardial fibrosis; miR-29 did not differ between groups |
Zhang et al[25] | Case-control study | 25 | 21 HCM patients, 4 controls | 68 miRNAs detected by Agilent Human miRNA Microarray Kit | LGE by CMR | 22 miRNAs increased and 46 miRNAs decreased in HCM patients; miR-3960 and miR-652-3p levels correlated with LV hypertrophy; miR-642a-3p levels correlated with LV fibrosis |
Thottakara et al[16] | Case-control study | 40 | 24 HCM patients, 11 controls | 6 miRNAs quantified by Human v3 miRNA Expression Assay Kit Code set and validated by RT-PCR | LGE by CMR | Elevated miR-4454 levels correlated with fibrosis in HCM patients |
Huang et al[24] | Case-control study | 72 | 42 HOCM patients and 30 controls | 11 miRNAs initially detected by qRT-PCR; 2 further studied | Echocardiography and LGE by CMR | miR-221 correlated with myocardial fibrosis and hypertrophy in HOCM |
Zhou et al[27] | Case-control study | 69 | 30 HCM with fibrosis and 39 HCM without fibrosis patients | miR-29a assessed by qRT-PCR | Symptomatic assessment | lncRNA-MIAT associated with fibrosis in HCM by regulating miR-29a |
Fang et al[28] | Case-control study | 55 | 55 HCM patients | 16 miRNAs validated using Taqman PCR | LGE by CMR | 14 miRNAs upregulated in HCM patients; combination of 8 miRNAs showed high diagnostic value for diffuse myocardial fibrosis in HCM |
Roncarati et al[26] | Case-control study | 82 | 41 HCM patients, 41 controls | 21 miRNAs assessed by qRT-PCR | LGE by CMR | 12 miRNAs upregulated in HCM; 3 correlated with hypertrophy; only miR-29a correlated with hypertrophy and fibrosis |
Animal studies | ||||||
Zalivina et al[22] | Animal study | - | Murine mouse model | miR-199a-3p assessed by qPCR | N/A | miR-199a-3p contributed to cardiac fibrosis in HCM mice |
- Citation: Mylavarapu M, Kodali LSM, Vempati R, Nagarajan JS, Vyas A, Desai R. Circulating microRNAs in predicting fibrosis in hypertrophic cardiomyopathy: A systematic review. World J Cardiol 2025; 17(5): 106123
- URL: https://www.wjgnet.com/1949-8462/full/v17/i5/106123.htm
- DOI: https://dx.doi.org/10.4330/wjc.v17.i5.106123